Breaking News

South Dakota Becomes First State to Enact 340B Contract Pharmacy Access Law in 2025

South Dakota Gov. Larry Rhoden (R) has signed 97 bills into law in the 2025 legislative session, including a 340B contract pharmacy access bill.
South Dakota today became the first state in 2025 to enact a law prohibiting drugmakers from restricting 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Recap of Recent Webinar: A Closer Look at Battles Over State 340B Contract Pharmacy Access Bills and Laws

340B Report's latest webinar overviewed contract pharmacy developments in state legislatures and the courts, plus how a dark money group has ramped up anti-340B ads.
As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Allows Hospital Group to Join Government in Legal Battle Over Drugmaker 340B Rebate Models

U.S. District Judge Dabney L. Friedrich of the District of Columbia granted 340B Health's motion to intervene in four drugmaker rebate lawsuits on March 4.
A federal judge has ruled that a major hospital advocacy group and two of its members can join the government [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Michigan Senate Easily Passes Bill with 340B Contract Pharmacy Protections, Reporting Requirements for Providers and Manufacturers

On March 6, the Michigan Senate voted, 33-3, to pass a 340B contract pharmacy access bill with reporting provisions for both providers and drugmakers.
The Michigan Senate overwhelmingly approved a bill earlier today to prohibit drugmaker 340B contract pharmacy restrictions and place new reporting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Utah, South Dakota Legislatures Pass 340B Contract Pharmacy Access Bills in Landslide Votes, Sending to State Governors

The Utah House overwhelmingly voted to pass a contract pharmacy access bill the same day that South Dakota's House approved similar legislation.
The Utah House and South Dakota House both overwhelmingly voted yesterday to pass 340B contract pharmacy access legislation, sending those [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AstraZeneca Adds Three Specialty Cancer Drugs to 340B Contract Pharmacy Restrictions

AstraZeneca announced that beginning on April 1 its contract pharmacy restrictions will apply to three specialty cancer drugs.
A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Key Votes on 340B Contract Pharmacy Access Bills in Utah, New Mexico, Michigan; Bill Introductions in Kansas and Florida

Utah Rep. Steve Eliason (R), who introduced a 340B contract pharmacy access bill, unexpectedly put forward a motion to reconsider his bill 40 minutes after it unanimously passed the state House on Feb. 28.
State lawmakers in Utah, New Mexico, Michigan, Kansas and Florida have all recently voted on or introduced bills to prohibit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie Adds 340B Restrictions to Cancer, Parkinson’s Treatment Drugs

AbbVie announced that its contract pharmacy restrictions now apply to two new drugs: Elahere and Vyalev.
A Chicago-based drugmaker recently added two new medications to its growing list of drugs subject to 340B contract pharmacy restrictions.  [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eli Lilly, Eisai, GSK and Merck Announce 340B Refunds, Other Drugmakers Report NDC Changes

Several drugmakers notified covered entities of changes to their 340B drug ceiling prices and national drug codes in notices posted on the Health Resources and Services Administration’s website in January and February.
Several drugmakers recently notified covered entities of changes to their 340B drug ceiling prices, resulting in refunds, while others announced [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live